Brett Olson is a member of the commercial team at RIS Rx, where he supports clients with patient access strategies designed to protect gross‑to‑net (GTN) revenue. Through a consultative approach, he partners with manufacturers to identify and address payer-driven efforts that restrict patient affordability programs. Brett brings more than 23 years of comprehensive healthcare experience spanning market access, patient services, reimbursement, and SaaS technology solutions. He has held leadership roles with Eversana Specialty Consulting, Annexus Health, and 1798 Consultants, and gained extensive patient affordability and access expertise during his tenure at TrialCard. He holds a BSBA in Marketing from East Carolina University.
"*" indicates required fields
RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.
RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.